Two Colorado deaths reported in local 7-OH cases as officials urge caution

Why it matters

The report describes two fatal cases in Colorado involving 7-OH products and other substances, with local clinicians and law-enforcement officials calling for better consumer and provider information. It also illustrates why product concentration, co-use and labeling matter in real-world safety assessments.

The big picture

Kratom products vary widely, and 7-hydroxymitragynine (7-OH) may appear in concentrated formulations. The article is local reporting, not a controlled study, so it cannot establish causation beyond the determinations cited from medical examiners and officials.

Key findings

• A Routt County coroner cited complications of combined alprazolam and kratom toxicity in the May death of a 29-year-old Denver resident.
• A Grand Junction medical examiner reported drug 7-hydroxymitragynine intoxication as the cause of death of a 23-year-old man found in Craig in June.
• The report says a quarter of a 60 mg 7-OH tablet was observed in the first case; alcohol use and prescribed anxiety medication were also reported.
• Colorado's health department reports 240 deaths from 2020 through 2025 attributed to kratom/mitragynine alone or in combination with other drugs or substances.
• Local clinicians said that combining kratom-derived compounds with central-nervous-system depressants may increase health risks.

What they say

University of Colorado Anschutz pharmacology and toxicology professor David Kroll said natural and semi-synthetic kratom compounds have “great health risks when combined with any other depressant of the central nervous system.”

Bottom line

**The local cases reinforce that concentrated 7-OH products and co-use with sedating substances require careful safety attention.**